Company profile & Management

Sensible Medical Innovations is the market leader in medical radar (ReDS™) monitoring and imaging technology. The technology is well-positioned to be a game changer in a wide range of applications and to become the next-generation lung fluid monitoring modality.

Vision – Striving to lead a new
Standard of Care in Heart Failure

ReDS™ enables the noninvasive monitoring and management of patients with fluid management problems. Lung fluid levels matter in the treatment of Heart Failure patients, and ReDS™ is designed with the needs of these patients in mind.

Sensible Medical is striving to lead the way toward a new standard of care for Heart Failure (HF), by giving healthcare professionals and patients a credible tool in the measurement of lung fluid, inside and outside the clinic setting.

Mission – To Empower Heart Failure
Professionals and Patients

Through ReDS™, Sensible Medical empowers Heart Failure professionals and patients by providing accurate, actionable, and absolute lung fluid measurements across the continuum of care. Our groundbreaking ReDS™ technology monitors the patient’s lung fluid status and serves as a decision support tool for physicians, providing them with valuable information in determining the right course of treatment. ReDS™ opens the possibility for physicians to deliver adequate treatment while their patients are still in an asymptomatic stage of fluid accumulation, which, when combined with other treatments, may help prevent symptoms that could lead to harmful Heart Failure deterioration in the future.

Management team

Abraham Ludomirski,

CEO

John DeChellis,

President, US

Nahum Hai,

COO

 

Dr. Abraham (Avi) Ludomirski, CEO

Ludomirski previously served as the board chairman of Sensible Medical and has also held positions as a director or board chairman at other healthcare technology/device companies. Ludomirski founded and developed the SafeKeeping Company (remote monitoring of high-risk pregnancies). He currently serves on the board of Vishay Intertechnology (NYSE: VSH), a global leading manufacturer of semiconductors and passive electronic components. He has been a consultant to several Israeli and American venture capital funds and large medical technology companies. He earned his M.D. at the Sackler Tel-Aviv University Medical School, specializing in OB-GYN and completed his fellowship at the University of Pennsylvania in maternal fetal medicine. Ludomirski served as the Director of the Maternal Fetal Medicine Division and as a Professor of OB-GYN at Temple University Medical School. Ludomirski’s work in high-tech venture capital and medical fields gives him a valuable perspective on investment in and leadership of innovative technology companies.

John DeChellis, President, US

DeChellis joined Sensible Medical in 2017 as a Territory Sales Representative. He was promoted to Regional Sales Manager and then Vice President, Business Development after leading the US in ReDS™ sales and clinical expertise. His appointment to President, US will allow him to build out our commercial team and expand the reach of ReDS™ throughout the United States. Prior to joining the Sensible Medical team, DeChellis held executive positions for medical equipment and device companies including Philips, St Jude Medical, Lumenis and Covidien as well as other leading device and Med Tech companies. John holds a Bachelor of Science (BS) focused in Biology/Exercise Science.

Nahum Hai, COO

Nahum Hai joined Sensible Medical in 2010 as Chief Operating Officer. Prior to joining Sensible Medical, Mr. Hai led the departments of VAS Engineering, Service Development, and 3G Engineering at Cellcom, (NYSE:CEL), Israel’s largest cellular operator.
From 2001 to 2010, Mr. Hai worked at Cellcom in roles of increasing responsibility. Most recently, Mr. Hai served as the Department Manager of Advanced Services. At Cellcom, Mr. Hai led project/product management, system integrations, and development, and managed the delivery of cross-organizational, complex customer projects that served over 1M active users and generated tens of millions of dollars in revenues. Mr. Hai managed SW development of content delivery platforms and internet applications and was responsible for introducing new products from concept to support. He began his career in the Israel Defense Forces in 1995.
Mr. Hai holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, an M.A. in Business Administration from the Technion – Israel Institute of Technology, and an M.A. in Law with a specialization in Patent Law from Haifa University.

Shlomi Bergida,

VP Product Management

 

Nadav Mizrahi,

VP R&D

 

Amir Saroka, CTO

Amir Saroka co-founded Sensible Medical Innovations in 2007, and now serves as Chief Technology Officer. Prior to founding Sensible Medical, Mr. Saroka was the department manager of an elite R&D unit in the Israel Defense Forces.
From 1997 to 2005, Mr. Saroka headed projects for the Israeli Ministry of Defense in the areas of wireless and wired communication, software engineering, embedded software, signal processing, digital circuit design and more.
Mr. Saroka holds an M.Sc. in Electrical Engineering from Tel-Aviv University, and a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology.

Shlomi Bergida, VP Product Management

Shlomi Bergida co-founded Sensible Medical in 2007, and now serves as VP of Product Management. Prior to founding Sensible Medical, Mr. Bergida held positions of increasing responsibility with an elite electronics R&D unit in the Israeli Ministry of Defense.
From 1998 to 2006, Mr. Bergida headed various large-scale projects of R&D activities for the Israeli Defense Forces, where he developed his areas of expertise in multidisciplinary system definition, design, and implementation.
Mr. Bergida holds an M.Sc. in Electrical Engineering from Tel-Aviv University in Israel and a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology.

Nadav Mizrahi, VP R&D

Nadav Mizrahi joined Sensible Medical in 2007 and now serves as VP of R&D. Prior to joining Sensible Medical, Mr. Mizrahi served at an elite electronics R&D unit in the Israeli Ministry of Defense.
From 1998 to 2006, Mr. Mizrahi led the research and development of various digital and analogue platforms designed to fit within high performance and reliable communication systems. During his time with the Israeli Defense Forces, Mr. Mizrahi developed deep expertise in system design, high-performance digital hardware, microwave systems, ASIC and board level design, as well as R&D and QA team management.
Mr. Mizrahi holds an M.Sc. in Bio-Medical Engineering and a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology.

Amir Ronen, CEO

Amir Ronen founded Sensible Medical Innovations in 2007 with the aim of bringing top notch technology innovations to the area of heart failure care. Prior to founding Sensible Medical, he held executive positions at leading global companies, including M-Systems, Intel, and Saifun. In his previous role as VP of Marketing & Business Development at M-Systems (previously NSDQ:FLSH), Mr. Ronen initiated the breakthrough ‘X4 technology’ that revolutionized the flash memory market. Prior to that, at Intel Corp (NSDQ: INTC), he led Intel’s flagship paradigm shift microprocessor.

Amir holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, and an MBA from the Kellogg (Northwestern University)-Recanati (Tel-Aviv University) International Executive MBA program.

Amir Ronen, CEO

Amir Ronen founded Sensible Medical Innovations in 2007 with the aim of bringing top notch technology innovations to the area of heart failure care. Prior to founding Sensible Medical, he held executive positions at leading global companies, including M-Systems, Intel, and Saifun. In his previous role as VP of Marketing & Business Development at M-Systems (previously NSDQ:FLSH), Mr. Ronen initiated the breakthrough ‘X4 technology’ that revolutionized the flash memory market. Prior to that, at Intel Corp (NSDQ: INTC), he led Intel’s flagship paradigm shift microprocessor.

Amir holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, and an MBA from the Kellogg (Northwestern University)-Recanati (Tel-Aviv University) International Executive MBA program.

Amir Ronen, CEO

Amir Ronen founded Sensible Medical Innovations in 2007 with the aim of bringing top notch technology innovations to the area of heart failure care. Prior to founding Sensible Medical, he held executive positions at leading global companies, including M-Systems, Intel, and Saifun. In his previous role as VP of Marketing & Business Development at M-Systems (previously NSDQ:FLSH), Mr. Ronen initiated the breakthrough ‘X4 technology’ that revolutionized the flash memory market. Prior to that, at Intel Corp (NSDQ: INTC), he led Intel’s flagship paradigm shift microprocessor.

Amir holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, and an MBA from the Kellogg (Northwestern University)-Recanati (Tel-Aviv University) International Executive MBA program.

Amir Ronen, CEO

Amir Ronen founded Sensible Medical Innovations in 2007 with the aim of bringing top-notch technology innovations to the area of heart failure care. Prior to founding Sensible Medical, he held executive positions at leading global companies, including M-Systems, Intel, and Saifun. In his previous role as VP of Marketing & Business Development at M-Systems (previously NSDQ:FLSH), Mr. Ronen initiated the breakthrough ‘X4 technology’ that revolutionized the flash memory market. Prior to that, at Intel Corp (NSDQ: INTC), he led Intel’s flagship paradigm shift microprocessor. Amir holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, and an MBA from the Kellogg (Northwestern University)-Recanati (Tel-Aviv University) International Executive MBA program.

Ben Royster,  President and CCO, US

Ben joined Sensible Medical in April 2022 as VP of Business Development and was appointed President and Chief Commercial Officer in October 2022. Prior to joining the Sensible Medical team, Ben spent the majority of his career at St. Jude Medical holding various senior leadership positions, most recently as the Vice President, Cardiac Sales Southeast.

Ben holds a Bachelor of Science (B.S.) degree in Business Administration, Management and Operations from Strome College of Business

Nahum Hai, COO

Nahum Hai joined Sensible Medical in 2010 as Chief Operating Officer.  Prior to joining Sensible Medical, Mr. Hai led the departments of VAS Engineering, Service Development, and 3G Engineering at Cellcom, (NYSE:CEL), Israel’s largest cellular operator. From 2001 to 2010, Mr. Hai worked at Cellcom in roles of increasing responsibility. Most recently, Mr. Hai served as the Department Manager of Advanced Services. At Cellcom, Mr. Hai led project/product management, system integrations and development, and managed the delivery of cross-organizational, complex customer projects that served over 1M active users and generated tens of millions of dollars in revenues. Mr. Hai managed SW development of content delivery platforms and internet applications, and was responsible for introducing new products from concept to support. He began his career in the Israel Defense Forces in 1995. Mr. Hai holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, an M.A. in Business Administration from the Technion – Israel Institute of Technology, and an M.A. in Law with a specialization in Patent Law from Haifa University.

Amir Saroka, CTO

Amir Saroka co-founded Sensible Medical Innovations in 2007, and now serves as Chief Technology Officer. Prior to founding Sensible Medical, Mr. Saroka was the department manager of an elite R&D unit in the Israel Defense Forces. From 1997 to 2005, Mr. Saroka headed projects for the Israeli Ministry of Defense in the areas of wireless and wired communication, software engineering, embedded software, signal processing, digital circuit design and more. Mr. Saroka holds an M.Sc. in Electrical Engineering from Tel-Aviv University, and a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology.

Shlomi Bergida, VP Product Management

Shlomi Bergida co-founded Sensible Medical in 2007, and now serves as VP of Product Management. Prior to founding Sensible Medical, Mr. Bergida held positions of increasing responsibility with an elite electronics R&D unit in the Israeli Ministry of Defense. From 1998 to 2006, Mr. Bergida headed various large-scale projects of R&D activities for the Israeli Defense Forces, where he developed his areas of expertise in multidisciplinary system definition, design, and implementation. Mr. Bergida holds an M.Sc. in Electrical Engineering from Tel-Aviv University in Israel and a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology.

Nadav Mizrahi, VP R&D

Nadav Mizrahi joined Sensible Medical in 2007, and now serves as VP of R&D. Prior to joining Sensible Medical, Mr. Mizrahi served at an elite electronics R&D unit in the Israeli Ministry of Defense. From 1998 to 2006, Mr. Mizrahi led the research and development of various digital and analogue platforms designed to fit within high performance and reliable communication systems. During his time with the Israeli Defense Forces, Mr. Mizrahi developed deep expertise in system design, high performance digital hardware, micro-wave systems, ASIC and board level design, as well as R&D and QA team management. Mr. Mizrahi holds a M.Sc. in Bio-Medical Engineering and a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology.